Medtronic, IBM Watson Health launch AI-powered diabetes management app

This article was originally published here

Medtronic (NYSE:MDT), in partnership with IBM Watson Health, this week announced commercial availability of its AI-powered Sugar.IQ diabetes management app.

Using artificial intelligence, the Sugar.IQ app evaluates how a user’s blood sugar levels respond to variables such as food intake, insulin dosing and other daily routines.

Get the full story at our sister site, Drug Delivery Business News.

The post Medtronic, IBM Watson Health launch AI-powered diabetes management app appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply